Impaired olfaction and other prodromal features in the Parkinson At-Risk Syndrome Study.
about
The Progressive BSSG Rat Model of Parkinson's: Recapitulating Multiple Key Features of the Human DiseaseImpaired trunk stability in individuals at high risk for Parkinson's diseaseAn update on the diagnosis and treatment of Parkinson diseasePlasma apolipoprotein A1 as a biomarker for Parkinson diseasePREDICT-PD: identifying risk of Parkinson's disease in the community: methods and baseline resultsThe utility of magnetic resonance imaging in the diagnostic evaluation of idiopathic olfactory loss.Tracking Parkinson's: Study Design and Baseline Patient Data.Blood-based biomarkers for Parkinson's diseaseLow clinical diagnostic accuracy of early vs advanced Parkinson disease: clinicopathologic studyDefining at-risk populations for Parkinson's disease: lessons from ongoing studies.Non-motor Parkinson's: integral to motor Parkinson's, yet often neglected.Premotor and nonmotor features of Parkinson's disease.Imaging prodromal Parkinson disease: the Parkinson Associated Risk Syndrome Study.Olfactory identification in LRRK2 G2019S mutation carriers: a relevant marker?Unbiased approaches to biomarker discovery in neurodegenerative diseasesMeta-analyses on prevalence of selected Parkinson's nonmotor symptoms before and after diagnosisProdromal features for Parkinson's disease--baseline data from the TREND study.Identifying the clusters within nonmotor manifestations in early Parkinson's disease by using unsupervised cluster analysis.Alpha-synuclein in peripheral tissues and body fluids as a biomarker for Parkinson's disease - a systematic review.Bradykinesia-akinesia incoordination test: validating an online keyboard test of upper limb functionPotential sex differences in nonmotor symptoms in early drug-naive Parkinson diseaseAssessment of Olfactory Function in MAPT-Associated Neurodegenerative Disease Reveals Odor-Identification Irreproducibility as a Non-Disease-Specific, General Characteristic of Olfactory DysfunctionCan a screening questionnaire accurately identify mild Parkinsonian signs?Sensory aspects of movement disorders.In vivo neurochemical imaging of olfactory dysfunction in Parkinson's disease.Cognition in individuals at risk for Parkinson's: Parkinson associated risk syndrome (PARS) study findings.Olfactory dysfunction in incidental Lewy body disease and Parkinson's diseaseField Survey Measures of Olfaction: The Olfactory Function Field Exam (OFFE).Variation in Recent Onset Parkinson's Disease: Implications for Prodromal Detection.Research on the premotor symptoms of Parkinson's disease: clinical and etiological implications.PREDICT-PD: An online approach to prospectively identify risk indicators of Parkinson's disease.Neuropathological Staging of Brain Pathology in Sporadic Parkinson's disease: Separating the Wheat from the Chaff.The significance of defining preclinical or prodromal Parkinson's disease.Combined assessment of midbrain hyperechogenicity, hyposmia and motor asymmetry improves diagnostic accuracy in early Parkinson's disease.Overcoming obstacles in Parkinson's disease.Olfactory loss as a supporting feature in the diagnosis of Parkinson's disease: a pragmatic approach.Biomarkers for the diagnosis and management of Parkinson's disease.Is there a need to redefine Parkinson's disease?Surgical management of airway dysfunction in Parkinson's disease compared with Parkinson-plus syndromes.Recent developments in biomarkers in Parkinson disease
P2860
Q27315090-AB1D11D4-BA9E-4597-8127-0D2EF0000B95Q28730962-301FFB68-D7BC-4703-998D-F2609B31A069Q30243899-468231D3-9D8F-46A9-9091-49538CE01223Q30544798-8A4C29F5-66DF-443F-85E2-12902AE0BC5AQ30564071-A56B168C-4C41-4B2E-B577-90B5C0DF6DA4Q30649922-93CBFB91-467C-45BE-B887-1934A80354B1Q31008758-BDD52C4A-5299-4478-8D2A-FF99564095D9Q33804255-B2518409-4039-46E5-9089-7BFB96386F81Q34043770-87A6382A-BAB9-4DC6-A81E-84A5877B37EEQ34234632-25F3ACD7-377B-4BF1-B3BB-7D6B8D31D5A4Q34239492-E886475B-AC08-4B30-81A0-DC009A380FC9Q34274224-9B86B2FB-27A1-4063-8F71-00973EE74ECCQ34553777-3B530F40-7D10-4203-A581-5ADC5D9DA42DQ34562789-71A14ED9-2DF7-443C-BEFB-960BF2549ADEQ34625918-EF290B2D-8019-47BF-9D18-314A3583C784Q35066107-878E1943-68C6-409B-89CF-B1544492C0EBQ35115470-51B2514F-FD04-4859-94F4-8ADACDB428E8Q35124218-F326C254-7616-4A10-BC06-704C6521D93BQ35139572-3F11B3E2-59DD-48E1-BC5F-8D800E92B4E9Q35159798-6CF09A3A-A3F4-443A-8B08-86A5800D53F6Q35671020-1D97EF9C-F484-44CC-B6DF-CA5FD08C8874Q36195000-42E528EB-EB1E-43CE-AA36-102C38648B6BQ36443271-E25C57B1-22FF-4F52-A7CE-95D67104EFF5Q36595746-BF13753F-0E0F-4CFF-9A37-B2267AA2F622Q36728836-B53F0BAD-8314-438C-A67B-1C9991C40A9DQ36785957-9A86DF0E-5BD9-4E5A-805B-0E5C2E2C50B9Q36808303-F6299C1F-A06E-4AD6-B40F-A848BC99DD74Q36926889-991CDAED-779F-4808-A766-E151F250D032Q37054007-45E76DE0-6B57-4E47-A78E-1B8F833A6E45Q37374203-AB8D7700-6E02-4B81-A72B-19BEB39CE0CEQ37663889-D732C1D2-E3DF-4656-B6C5-6010EB03C073Q37693339-B633CC40-9A11-4EF8-B37E-685EC43BDA6FQ38003068-245BEE25-BC87-463F-86D4-7DEDABA1876EQ38045906-84E50637-EE0D-4755-9589-C92910CA6023Q38056875-BF78ECE3-4494-4F5A-8510-32DEB462D282Q38078791-F48721F7-7A3C-4B68-85D1-A742856E9B95Q38093247-41F3976E-B3CC-4E28-8985-EF13C63CCFE6Q38110209-93D2ABD5-3F8B-48B4-83DE-3FC35D72A610Q38118332-0AF95513-5FA1-4393-B091-70EF7A93CEA8Q38119095-6B6C4CAF-3B38-4E99-8630-F38B2597E4B9
P2860
Impaired olfaction and other prodromal features in the Parkinson At-Risk Syndrome Study.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Impaired olfaction and other prodromal features in the Parkinson At-Risk Syndrome Study.
@en
Impaired olfaction and other prodromal features in the Parkinson At-Risk Syndrome Study.
@nl
type
label
Impaired olfaction and other prodromal features in the Parkinson At-Risk Syndrome Study.
@en
Impaired olfaction and other prodromal features in the Parkinson At-Risk Syndrome Study.
@nl
prefLabel
Impaired olfaction and other prodromal features in the Parkinson At-Risk Syndrome Study.
@en
Impaired olfaction and other prodromal features in the Parkinson At-Risk Syndrome Study.
@nl
P2093
P356
P1433
P1476
Impaired olfaction and other prodromal features in the Parkinson At-Risk Syndrome Study
@en
P2093
Albert Ascherio
Andrew Siderowf
Danna Jennings
David Oakes
Kenneth Marek
Matthew B Stern
PARS Investigators
Shirley Eberly
P304
P356
10.1002/MDS.24892
P407
P577
2012-01-11T00:00:00Z